Treatment of asymptomatic carriers with artemether-lumefantrine: An opportunity to reduce the burden of malaria?

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Ogutu, Bernhards ^a,b   Tiono, Alfred B ^c   Makanga, Michael ^d   Premji, Zulfiqarali ^e   Gbadoé, Adama Dodji ^f   Ubben, David ^g   Marrast, Anne Claire ^h   Gaye, Oumar ⁱ  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b Studies of the Epidemiology of Epilepsy in Demographic Surveillance Systems   (Kenya)

^c Burkina Faso   (Burkina Faso)

^d European and Developing Countries Clinical Trials   (South Africa)

^e MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^f UNIVERSITY OF LOMÉ   (Togo)

^g Medicines for Malaria Venture   (Switzerland)

^h NOVARTIS PHARMA AG   (Switzerland)

ⁱ UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

AFRICA SOUTH OF THE SAHARA; ARTICLE; BLOOD; COST OF ILLNESS; DISEASE TRANSMISSION; DRUG COMBINATION; DRUG EFFECT; FEMALE; HEALTH SURVEY; HETEROZYGOTE; HUMAN; INCIDENCE; ISOLATION AND PURIFICATION; MALARIA FALCIPARUM; MALE; PARASITEMIA; PARASITOLOGY; PLASMODIUM FALCIPARUM; PREVALENCE; RISK; TREATMENT OUTCOME;

AFRICA SOUTH OF THE SAHARA; ANTIMALARIALS; ARTEMISININS; CARRIER STATE; COST OF ILLNESS; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; INCIDENCE; MALARIA, FALCIPARUM; MALE; PARASITEMIA; PLASMODIUM FALCIPARUM; POPULATION SURVEILLANCE; PREVALENCE; RISK; TREATMENT OUTCOME;

EID: 77649289117     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-30     Document Type: Review

References (51)

1. Initial evidence of reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and treatment. Otten M, Aregawi M, Were W, Karema C, Medin A, Bekele W, Jima D, Gausi K, Komatsu R, Korenromp E, Low-Beer D, Grabowsky M, Malar J 2009 8 14 10.1186/1475-2875-8-14 19144183
2. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. Bhattarai A, Ali AS, Kachur SP, Mårtensson A, Abbas AK, Khatib R, Al-mafazy A-W, Ramsan M, Rotllant G, Gerstenmaier JF, Molteni F, Abdulla S, Montgomery SM, Kaneko A, Björkman A, PLoS Med 2007 4 309 10.1371/journal.pmed.0040309 17988171 (Pubitemid 350220531)
3. Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Ceesay SJ, Casals-Pascual C, Erskine J, Anya SE, Duah NO, Fulford AJC, Sesay SS, Abubakar I, Dunyo S, Sey O, Palmer A, Fofana M, Corrah T, Bojang KA, Whittle HC, Greenwood BM, Conway DJ, Lancet 2008 372 1545 1554 10.1016/S0140-6736(08)61654-2 18984187
4. Seven years of regional malaria control collaboration-Mozambique, South Africa, and Swaziland. Sharp BL, Kleinschmidt I, Streat E, Maharaj R, Barnes KI, Durrheim DN, Ridl FC, Morris N, Seocharan I, Kunene S, La Grange JJP, Mthembu JD, Maartens F, Martin CL, Barreto A, Am J Trop Med Hyg 2007 76 42 47 17255227 (Pubitemid 351627800)
5. A country-wide malaria survey in Mozambique. II. Malaria attributable proportion of fever and establishment of malaria case definition in children across different epidemiological settings. Mabunda S, Aponte JJ, Tiago A, Alonso P, Malar J 2009 8 74 10.1186/1475-2875-8-74 19383126
6. Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants. Vafa M, Troye-Blomberg M, Anchang J, Garcia A, Migot-Nabias F, Malar J 2008 7 17 10.1186/1475-2875-7-17 18215251 (Pubitemid 351378200)
7. High prevalence of asymptomatic Plasmodium falciparum infection in Gabonese adults. Dal-Bianco MP, Köster KB, Kombila UD, Kun JF, Grosbusch MP, Mombo Ngoma G, Matsiegui PB, Supan C, Opsina Salazar CL, Missinou MA, Issifou S, Lell B, Kremsner P, Am J Trop Med Hyg 2007 77 939 942 17984357 (Pubitemid 351837845)
8. Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum. Dunyo S, Miligan P, Edwards T, Sutherland C, Targett G, Pinder M, PLoS Clinical Trials 2006 1 20 10.1371/journal.pctr.0010020 17013431
9. High prevalence of asymptomatic Plasmodium falciparum infections in a highland area of western Kenya: a cohort study. Baliraine FN, Afrane YA, Amenya DA, Bonizzoni M, Menge DM, Zhou G, Zhong D, Vardo-Zalik AM, Githeko AK, Yan G, J Infect Dis 2009 200 66 74 10.1086/599317 19476434
10. Relation between Plasmodium falciparum asymptomatic infection and malaria attacks in a cohort of Senegalese children. Le Port A, Cot M, Etard J-F, Gaye O, Migot-Nabias F, Garcia A, Malar J 2008 7 193 10.1186/1475-2875-7-193 18823542
11. Long-term asymptomatic carriage of Plasmodium falciparum protects from malaria attacks: a prospective study among Senegalese children. Males S, Gaye O, Garcia A, Clin Infect Dis 2008 46 516 522 10.1086/526529 18199040 (Pubitemid 351263488)
12. Dynamics of gametocytes among Plasmodium falciparum clones in natural infections in an area of highly seasonal transmission. Abdel-Wahab A, Abdel-Muhsin AM, Ali E, Suleiman S, Ahmed S, Walliker D, Babiker HA, J Infect Dis 2002 185 1838 1842 10.1086/340638 12085337 (Pubitemid 34615485)
13. Impact of genetic complexity on longevity and gametocytogenesis of Plasmodium falciparum during the dry and transmission-free season of eastern Sudan. Nassir E, Abdel-Muhsin AM, Suliaman S, Kenyon F, Kheir A, Geha H, Ferguson HM, Walliker D, Babiker HA, Int J Parasitol 2005 35 49 55 10.1016/j.ijpara.2004.10.014 15619515 (Pubitemid 41556671)
14. Effects of artemisinin derivatives on malaria transmissibility. Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ, Lancet 1996 347 1654 1658 10.1016/S0140-6736(96)91488-9 8642959 (Pubitemid 26177386)
15. A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children. Von Seidlein L, Bojang K, Jones P, Jaffar S, Pinder M, Obaro S, Doherty T, Haywood M, Snounou G, Gemperli B, Gathmann I, Royce C, McAdam K, Greenwood B, Am J Trop Med Hyg 1998 58 638 644 9598454 (Pubitemid 28237264)
16. Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. Sutherland CJ, Ord R, Dunyo S, Jawara M, Drakeley CJ, Alexander N, Coleman R, Pinder M, Walraven G, Targett GAT, PLoS Med 2005 2 92 10.1371/journal.pmed.0020092 15839740 (Pubitemid 40721079)
17. Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. van Vugt M, Wilairatana P, Gemperli B, Gathmann I, Phaipun L, Brockman A, Luxemburger C, White NJ, Nosten F, Looareesuwan S, Am J Trop Med Hyg 1999 60 936 942 10403324 (Pubitemid 29296218)
18. Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. Van Vugt M, Looareesuwan S, Wilairatana P, McGready R, Villegas L, Gathmann I, Mull R, Brockman A, White NJ, Nosten F, Trans R Soc Trop Med Hyg 2000 94 545 548 10.1016/S0035-9203(00)90082-8 11132386
19. A clinical and pharmacokinetic trial of six doses of artemether- lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. Lefévre G, Looareesuwan S, Treeprasertsuk S, Krudsood S, Silachamroon U, Gathmann I, Mull R, Bakshi R, Am J Trop Med Hyg 2001 64 247 256 11463111
20. Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial. Abdulla S, Sagara I, Borrmann S, D'Alessandro U, González R, Hamel M, Ogutu B, Mårtensson A, Lyimo J, Maiga H, Sasi P, Nahum A, Bassat Q, Juma E, Otieno L, Björkman A, Beck HP, Andriano K, Cousin M, Lefèvre G, Ubben D, Premji Z, Lancet 2008 372 1819 1827 10.1016/S0140-6736(08)61492-0 18926569
21. Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in non-immune populations: a safety, efficacy, and pharmacokinetic study. Hatz C, Soto J, Nothdurft HD, Zoller T, Weitzel T, Loutan L, Bricaire F, Gay F, Burchard G-D, Andriano K, Lefèvre G, Ibarra De Palacios P, Genton B, Am J Trop Med Hyg 2008 78 241 247 18256423 (Pubitemid 351844558)
22. Efficacy and safety of artemether-lumefantrine (Coartem§ssup§ ®§esup§) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria. Falade C, Makanga M, Premji Z, Ortmann C-E, Stockmeyer M, Ibarra de Palacios P, Trans R Soc Trop Med Hyg 2005 99 459 467 10.1016/j.trstmh.2004.09.013 15837358 (Pubitemid 40521344)
23. Mass administrations of antimalarial drugs. Von Seidlein L, Greenwood BM, Trends Parasitol 2003 19 452 460 10.1016/j.pt.2003.08.003 14519583 (Pubitemid 38366142)
24. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. White NJ, Pongtavornpinyo W, Maude RJ, Saralamba S, Aguas R, Stepniewska K, Lee SJ, Dondorp AM, White LJ, Day NPJ, Malaria J 2009 8 253 10.1186/1475-2875-8-253
25. Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria. Ashley EA, Stepniewska K, Lindegårdh N, McGready R, Hutagalung R, Hae R, Singhasivanon P, White NJ, Nosten F, Antimicrob Agents Chemother 2006 50 2281 2285 10.1128/AAC.00040-06 16801402 (Pubitemid 43993164)
26. The pharmacokinetics of three multiple dose regimens of chloroquine: implications for malaria chemoprophylaxis. Wetsteyn JC, De Vries PJ, Oosterhuis B, Van Boxtel CJ, Br J Clin Pharmacol. 1995 39 6 696 699 7654492
27. Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand. Tarning J, Ashley EA, Lindegardh N, Stepniewska K, Phaiphun L, Day NP, McGready R, Ashton M, Nosten F, White NJ, Antimicrob Agents Chemother 2008 52 1052 1061 10.1128/AAC.00955-07 18180343 (Pubitemid 351358388)
28. Pharmacokinetic determinants of the window of selection for antimalarial drug resistance. Stepniewska K, White NJ, Antimicrob Agents Chemother 2008 52 1589 1596 10.1128/AAC.00903-07 18299409 (Pubitemid 351614647)
29. WHO World Malaria Report 2008. http://www.who.int/malaria/wmr2008
30. Artemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa. Muheki C, McIntyre D, Barnes KI, Trop Med Int Health 2004 9 959 966 10.1111/j.1365-3156.2004.01292.x 15361108 (Pubitemid 39278996)
31. The economic and social burden of malaria. Sachs J, Malaney P, Nature 2002 415 680 685 10.1038/415680a 11832956 (Pubitemid 34136401)
32. Anaemia caused by asymptomatic Plasmodium falciparum infection in semi-immune African schoolchildren. Kurtzhals JA, Addae MM, Akanmori BD, Dunyo S, Koram KA, Appawu MA, Nkrumah FK, Hviid L, Trans R Soc Trop Med Hyg 1999 93 623 627 10.1016/S0035-9203(99)90073-1 10717750 (Pubitemid 30015789)
33. Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children. Bloland PB, Boriga DA, Ruebush TK, McCormick JB, Roberts JM, Oloo AJ, Hawley W, Lal A, Nahlen B, Campbell CC, Am J Trop Med Hyg 1999 60 641 648 10348241 (Pubitemid 29233123)
34. Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial. Clarke SE, Jukes MC, Njagi JK, Khasakhala L, Cundill B, Otido J, Crudder C, Estambale BB, Brooker S, Lancet 2008 372 127 138 10.1016/S0140-6736(08)61034-X 18620950 (Pubitemid 351952258)
35. Prevalence and severity of anemia and iron deficiency: cross-sectional studies in adolescent schoolgirls in western Kenya. Leenstra T, Kariuki SK, Kurtis JD, Oloo AJ, Kager PA, ter Kuile FO, Eur J Clin Nutr 2004 58 4 681 91 10.1038/sj.ejcn.1601865 15042138 (Pubitemid 38500140)
36. Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. Haas JD, Brownlie T 4th, J Nutr 2001 131 suppl 676S 690S 11160598 (Pubitemid 32115345)
37. Anemia and iron deficiency: effects on pregnancy outcome. Allen LH, Am J Clin Nutr 2000 71 suppl 1280S 1284S 10799402 (Pubitemid 30230529)
38. Iron treatment normalizes cognitive functioning in young women. Murray-Kolb LE, Beard JL, Am J Clin Nutr 2007 85 778 787 17344500 (Pubitemid 46393510)
39. Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi. Bell DJ, Wootton D, Mukaka M, Montgomery J, Kayange N, Chimpeni P, Hughes DA, Molyneux ME, Ward SA, Winstanley PA, Lalloo DG, Malar J 2009 8 204 10.1186/1475-2875-8-204 19709418
40. Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: a randomised controlled trial. Rahman MM, Dondorp AM, Day NP, Lindegardh N, Imwong M, Faiz MA, Bangali AM, Kamal AT, Karim J, Kaewkungwal J, Singhasivanon P, Trans R Soc Trop Med Hyg 2008 102 861 867 10.1016/j.trstmh.2008.05.022 18606428
41. Child mortality in a West African population protected with insecticide-treated curtains for a period of up to 6 years. Diallo DA, Cousens SN, Cuzin-Ouattara N, Nebié I, Ilboudo-Sanogo E, Esposito F, Bull World Health Organ 2004 82 85 91 15042229 (Pubitemid 38282055)
42. Mortality in a seven-and-a-half-year follow-up of a trial of insecticide-treated mosquito nets in Ghana. Binka FN, Hodgson A, Adjuik M, Smith T, Trans R Soc Trop Med Hyg 2002 96 597 599 10.1016/S0035-9203(02)90321-4 12625130 (Pubitemid 36231476)
43. Impact of permethrin-treated bed nets on malaria and all-cause morbidity in young children in an area of intense perennial malaria transmission in western Kenya: cross-sectional survey. Ter Kuile FO, Terlouw DJ, Phillips-Howard PA, Hawley WA, Friedman JF, Kolczak MS, Kariuki SK, Shi YP, Kwena AM, Vulule JM, Nahlen BL, Am J Trop Med Hyg 2003 68 suppl 4 100 107 12749492 (Pubitemid 38240688)
44. Impact of intermittent preventive treatment with sulphadoxine- pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali. Dicko A, Sagara I, Sissoko MS, Guindo O, Diallo AI, Kone M, Toure OB, Sacko M, Doumbo OK, Malar J 2008 7 123 10.1186/1475-2875-7- 123 18611271
45. Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial. Schellenberg D, Menendez C, Aponte JJ, Kahigwa E, Tanner M, Mshinda H, Alonso P, Lancet 2005 365 1481 1483 10.1016/S0140-6736(05)66418-5 15850632 (Pubitemid 40591693)
46. Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial. Massaga JJ, Kitua AY, Lemnge MM, Akida JA, Malle LN, Rønn AM, Theander TG, Bygbjerg IC, Lancet 2003 361 1853 1860 10.1016/S0140-6736(03)13504-0 12788572 (Pubitemid 36645180)
47. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. Cissé B, Sokhna C, Boulanger D, Milet J, Bâ EH, Richardson K, Hallett R, Sutherland C, Simondon K, Simondon F, Alexander N, Gaye O, Targett G, Lines J, Greenwood B, Trape J-F, Lancet 2006 367 659 667 10.1016/S0140-6736(06)68264-0 16503464 (Pubitemid 43289156)
48. Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomised, placebo controlled trial. Kweku M, Liu D, Adjuik M, Binka F, Seidu M, Greenwood B, Chandramohan D, PLoS ONE 2008 3 4000 10.1371/journal.pone.0004000 19098989
49. A randomized, double-blind, placebo-controlled, clinical trial of the impact of malaria prevention on the educational attainment of school children. Fernando SD, De Silva D, Carter R, Mendis KN, Wickremasinghe R, Am J Trop Med Hyg 2006 74 386 393 16525095 (Pubitemid 46774358)
50. A golden age for malaria research and innovation. Coll-Seck AM, Malar J 2008 7 suppl 1 2 10.1186/1475-2875-7-S1-S2 19091036
51. Towards a research agenda for global malaria elimination. Hommel M, Malar J 2008 7 suppl 1 1 10.1186/1475-2875-7-S1-S1 19091033